1. Home
  2. FNWB vs ANIX Comparison

FNWB vs ANIX Comparison

Compare FNWB & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

N/A

Current Price

$9.80

Market Cap

93.6M

Sector

Finance

ML Signal

N/A

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

N/A

Current Price

$3.16

Market Cap

103.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FNWB
ANIX
Founded
1923
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.6M
103.9M
IPO Year
2012
2013

Fundamental Metrics

Financial Performance
Metric
FNWB
ANIX
Price
$9.80
$3.16
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
★ $14.50
$9.67
AVG Volume (30 Days)
28.9K
★ 181.5K
Earning Date
10-29-2026
09-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 36.00
12.82
EPS
★ N/A
N/A
Revenue
$176,000.00
★ $210,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.50
N/A
P/E Ratio
$258.25
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$8.44
$2.32
52 Week High
$12.52
$5.46

Technical Indicators

Market Signals
Indicator
FNWB
ANIX
Relative Strength Index (RSI) 44.91 53.88
Support Level $9.50 $2.51
Resistance Level $10.30 $3.46
Average True Range (ATR) 0.31 0.21
MACD 0.05 0.02
Stochastic Oscillator 35.42 61.30

Price Performance

Historical Comparison
FNWB
ANIX

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It offers various products and services, such as commercial business loans, multi-family real estate loans, auto and consumer loans, transaction accounts, savings and money market accounts, online banking services, etc., focused on the lending, deposit, and money movement needs of individuals, businesses and nonprofit organizations. The Group's operations are mainly focused on serving various communities in Washington State, U.S. Substantially all of its income is derived from a diverse base of commercial, mortgage, and consumer lending activities and investments.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: